Risk of oncological diseases in patients with diabetes mellitus

QR Code

Risk of oncological diseases in patients with diabetes mellitus

В сентябрьском номере журнала Европейской ассоциации по изучению сахарного диабета (EASD) ?Diabetologia? была опубликована серия из четырех статей. В них анализировались эпидемиологические данные регистров Германии, Швеции, Шотландии и Великобритании о применении инсулина гларгин и риске развития ра...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Gagik Radikovich Galstyan
Format:	article
Langue:	EN RU
Publié:	Endocrinology Research Centre 2009
Sujets:	diabetes mellitus oncological diseases insulin glargin metformin sulfonylurea drugs Nutritional diseases. Deficiency diseases RC620-627
Accès en ligne:	https://doaj.org/article/a6fb583740b74009b6b485afdc432dfc
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Statin use and risk of diabetes mellitus
par: Oksana Mikhailovna Drapkina, et autres
Publié: (2012)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
par: Ivona Renata Yarek-Martynova, et autres
Publié: (2011)

National advisory board on diabetes mellitus: unsolved issues and new opportunities for diabetes treatment
par: Gagik Radikovich Galstyan
Publié: (2014)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
par: Tatiana Ivanovna Romantsova, et autres
Publié: (2013)

Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine?byHome P.D. & Lagarenne P. (Diabetologia 2009, vol. 52 (12): 2499-2506)
par: Marina Vladimirovna Shestakova, et autres
Publié: (2010)

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
par: Tatiana Ivanovna Romantsova, et autres
Publié: (2010)

Osteoporosis and diabetes mellitus: a modern viewpoint
par: Natalya Alexandrovna Molitvoslovova, et autres
Publié: (2013)

International guidelines on the study of glycated hemoglobin HbA1c level as a diagnostic criterion for diabetes mellitus and otherdisorders of carbohydrate metabolism
par: Gagik Radikovich Galstyan
Publié: (2010)

Mauriac syndrome in adult with type 1 diabetes mellitus
par: Natalya Alexandrovna Molitvoslovova, et autres
Publié: (2011)

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
par: Gagik Radikovich Galstyan
Publié: (2013)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
par: Alsu Gafurovna Zalevskaya, et autres
Publié: (2010)

Metformin and cancer mortality
par: Lev Mikhaylovich Bershteyn
Publié: (2010)

Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
par: Alla Vsevolodovna Rudakova
Publié: (2011)

Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
par: Gagik Radikovich Galstyan, et autres
Publié: (2015)

Type 2 diabetes therapy at the time of diagnosis. Glimepiride: property, efficiency, safety
par: Olga Mikhailovna Smirnova
Publié: (2009)

Feasibility of efficacious therapy of diabetes mellitus by sulfonylurea agents in neonates with KCNJII gene mutation: originalobservation
par: Andrey Olegovich Emel'yanov, et autres
Publié: (2009)

Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
par: Lyudmila Viktorovna Nedosugova
Publié: (2013)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
par: Alexander Sergeevich Ametov, et autres
Publié: (2010)

Humalog Mix 25 in the treatment of type 2 diabetes mellitus
par: Vladimir Ivanovich Zoloedov, et autres
Publié: (2012)

Multidimensional effects of metformin in patients with type 2 diabetes
par: Lyudmila A. Ruyatkina, et autres
Publié: (2017)

Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed?
par: Marina Vladimirovna Shestakova, et autres
Publié: (2015)

Diabetes mellitus due to biliary recurrent pancreatitis. Case report
par: Elena Alexandrovna Kharlashina, et autres
Publié: (2011)

On the safety of insulin Glargine
par: Ivan Ivanovich Dedov, et autres
Publié: (2009)

69th Scientific Session of American Diabetes Association (ADA), 5-9 June 2009, New Orlean
par: Gagik Radikovich Galstyan
Publié: (2009)

Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
par: Anna I. Sazonova, et autres
Publié: (2016)

Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study
par: Elena Valer'evna Biryukova, et autres
Publié: (2012)

MODY3 in the child with type 2 diabetes mellitus phenotype: case report
par: Tamara Leonidovna Kuraeva, et autres
Publié: (2013)

Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
par: Lev Mikhaylovich Bershteyn, et autres
Publié: (2014)

Russian Association of Endocrinologists reports commencement of Amaril clinical use
par: Editorial team Diabetes Mellitus
Publié: (2012)

Initial glucose-lowering therapy and risks of overall and cardiovascular mortality, myocardial infarction and stroke in patients with type2 diabetes
par: Inna Vladimirovna Misnikova, et autres
Publié: (2009)

What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019
par: Marina V. Shestakova, et autres
Publié: (2020)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
par: Natalya Vladislavovna Zaytseva, et autres
Publié: (2015)

Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
par: Editorial team Diabetes Mellitus
Publié: (2011)

Harold Himsworth, founder of diabetes classification: 105th anniversary of his birthday
par: Olga Sergeevna Fedorova
Publié: (2010)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
par: I Yu Demidova, et autres
Publié: (2009)

Alpha-lipoic acid in non-proliferative diabetic retinopathy treatment by Demydova T.Yu., Trachtenberg Yu.A.: article critique
par: Dmitriy Valentinovich Lipatov, et autres
Publié: (2011)

Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
par: Vadim V. Genkel, et autres
Publié: (2018)

«DIARISK» — the first national prediabetes and diabetes mellitus type 2 risk calculator
par: Marina V. Shestakova, et autres
Publié: (2021)

Upgrading Novopen insulin injection systems - 25 years experience
par: Gagik Radikovich Galstyan, et autres
Publié: (2011)

Obesity and type 2 diabetes: can we find a compromised treatment solution?
par: Gagik R. Galstyan, et autres
Publié: (2017)